Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announce they have entered into an exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US through Hikma’s affiliate, Hikma Pharmaceuticals USA Inc.
#21toWatch in 2020 - nine trailblazers on Cofinitive’s longlist revealed
We are delighted to feature nine of the longlisted companies on the innovative #21toWatch campaign and awards run by corporate communications consultancy Cofinitive.
PhoreMost and Boehringer Ingelheim in multi-project drug discovery alliance
Cambridge biopharma business PhoreMost has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim, one of the world-leading pharmaceutical companies developing innovative therapies for diseases with unsatisfactory treatments.
Government to fund building of bio fuel production plants
Orange peel, rubbish and fatbergs will be amongst the unlikely components used by four UK-based plants to produce green fuels with support from government funding.
Ieso Digital Health launches one-to-one appointment system for Step 2 mental health patients
A busy period for Ieso Digital Health has continued with the launch of a new one-to-one appointment system to help reduce waiting lists for NHS mental healthcare patients.
Catching Up with Tripism CEO Adam Kerr
Tripism once was known as the personalization poster child of Microsoft's travel program. It's matured since then. The platform has registered 1 million travelers and serves as an engagement platform that brings travelers, travel managers and suppliers together in a virtuous data cycle that benefits every participant, according to CEO Adam Kerr. He spoke this week with BTN editor-in-chief Elizabeth West.
Ieso Digital Health to trial online therapy tailored for diabetes patients
A Cambridge company has launched a clinical trial to measure the success of online cognitive behavioural therapy tailored for those with with type 2 diabetes.
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases.
Paragraf increases Series A round to £16.2m to accelerate product delivery
UK-based graphene electronics technology company Paragraf announces today the addition of £3.4m to its series A round, with Draper Esprit joining as significant investor, bringing the total to £16.2m.
Shenzhen investment boost for Crayfish.io
Double Business Weekly Awards entrant Crayfish.io announced its arrival in the 30th Anniversary competition with a major coup: Crayfish has entered the Cambridge UK/China Award as well as the International Trade category.
SubSLAM Live can stream 3D scans from seafloor to surface
3D scanning has its data management challenges, including rendering, transmitting and sharing large files of scanned data in order to get them to the right stakeholders. But imagine having those same problems when what you need to look at is underwater. Rovco, an underwater autonomous vehicle and robotics developer has created both the hardware and the technology to address this challenge by creating a process to stream its underwater 3D data in real-time.
New weapon in fight for net zero emissions economy
Controllis, which supplies hybrid power systems for mobile network operators and tower companies, has developed a carbon neutral site power system to help support a net zero emissions economy, established by the Paris Agreement.
Arecor announces positive headline results for first Phase I clinical trial of AT247, a novel formulation of insulin
Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces positive headline results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247.
Audio Analytic's context-sensing tech on the Qualcomm® Snapdragon™ 765 Mobile Platform
Today, Audio Analytic’s context-sensing technology is being demonstrated on the next-generation Qualcomm® Snapdragon™ 765 Mobile Platform with integrated 5G at the Qualcomm Snapdragon Tech Summit 2019.
PatientSource expands to sexual and mental health sectors
Electronic patient record provider PatientSource has signed a contract with The Brandon Centre to digitise the delivery of its services.
Privitar Joins AWS Partner Network Global Startups Program
Data privacy software company leverages AWS resources globally to accelerate comprehensive data privacy adoption in the cloud
Cambridge Innovation Capital attracts £1 billion of investment into Cambridge companies
Since its foundation, Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies, highlighting its dominant position at the heart of the innovation ecosystem.
Rovco launches live 3D subsea streaming system
ABERDEEN - Subsea technology company Rovco has launched “SubSLAM Live” a 3D streaming technology which allows clients to video and live stream 3D underwater pointclouds to any device in the world.
British EPR vendor PatientSource signs contract with London-based charity The Brandon Centre
This is the second charity in London that PatientSource will be working with this year.
Controllis launches carbon neutral power solution for off-grid and poor-grid telecom sites
Controllis Zero offsets CO2 emissions from power production with sustainable solar and biofuel system